Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 6 March 2012
Vol. 5, Issue 214, p. ra19
[DOI: 10.1126/scisignal.2001986]


Akt and ERK Control the Proliferative Response of Mammary Epithelial Cells to the Growth Factors IGF-1 and EGF Through the Cell Cycle Inhibitor p57Kip2

Devin T. Worster1, Tobias Schmelzle1*, Nicole L. Solimini1{dagger}, Eric S. Lightcap2, Bjorn Millard3, Gordon B. Mills4, Joan S. Brugge1{ddagger}, and John G. Albeck1

1 Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
2 Millennium Pharmaceuticals, Cambridge, MA 02139, USA.
3 Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
4 Department of Systems Biology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

* Present Address: Novartis Institutes for Biomedical Research, Disease Area Oncology, CH-4002 Basel, Switzerland.

{dagger} Present Address: Department of Genetics, Harvard University Medical School and Division of Genetics, Brigham and Women’s Hospital, Boston, MA 02115, USA.

Abstract: Epithelial cells respond to growth factors including epidermal growth factor (EGF), insulin-like growth factor 1 (IGF-1), and insulin. Using high-content immunofluorescence microscopy, we quantitated differences in signaling networks downstream of EGF, which stimulated proliferation of mammary epithelial cells, and insulin or IGF-1, which enhanced the proliferative response to EGF but did not stimulate proliferation independently. We found that the abundance of the cyclin-dependent kinase inhibitors p21Cip1 and p57Kip2 increased in response to IGF-1 or insulin but decreased in response to EGF. Depletion of p57Kip2, but not p21Cip1, rendered IGF-1 or insulin sufficient to induce cellular proliferation in the absence of EGF. Signaling through the PI3K (phosphatidylinositol 3-kinase)–Akt–mTOR (mammalian target of rapamycin) pathway was necessary and sufficient for the increase in p57Kip2, whereas MEK [mitogen-activated or extracellular signal–regulated protein kinase (ERK) kinase]–ERK activity suppressed this increase, forming a regulatory circuit that limited proliferation in response to unaccompanied Akt activity. Knockdown of p57Kip2 enhanced the proliferative phenotype induced by tumor-associated PI3K mutant variants and released mammary epithelial acini from growth arrest during morphogenesis in three-dimensional culture. These results provide a potential explanation for the context-dependent proliferative activities of insulin and IGF-1 and for the finding that the CDKN1C locus encoding p57Kip2 is silenced in many breast cancers, which frequently show hyperactivation of the PI3K pathway. The status of p57Kip2 may thus be an important factor to assess when considering targeted therapy against the ERK or PI3K pathways.

{ddagger} To whom correspondence should be addressed. E-mail: joan_brugge{at}

Citation: D. T. Worster, T. Schmelzle, N. L. Solimini, E. S. Lightcap, B. Millard, G. B. Mills, J. S. Brugge, J. G. Albeck, Akt and ERK Control the Proliferative Response of Mammary Epithelial Cells to the Growth Factors IGF-1 and EGF Through the Cell Cycle Inhibitor p57Kip2. Sci. Signal. 5, ra19 (2012).

Read the Full Text

Mechanisms of Resveratrol-Induced Inhibition of Clonal Expansion and Terminal Adipogenic Differentiation in 3T3-L1 Preadipocytes.
M. C. Mitterberger and W. Zwerschke (2013)
J Gerontol A Biol Sci Med Sci 68, 1356-1376
   Abstract »    Full Text »    PDF »
Anandamide-CB1 Receptor Signaling Contributes to Postnatal Ethanol-Induced Neonatal Neurodegeneration, Adult Synaptic, and Memory Deficits.
S. Subbanna, M. Shivakumar, D. Psychoyos, S. Xie, and B. S. Basavarajappa (2013)
J. Neurosci. 33, 6350-6366
   Abstract »    Full Text »    PDF »
Science Signaling Podcast: 6 March 2012.
J. G. Albeck, J. S. Brugge, and A. M. VanHook (2012)
Science Signaling 5, pc5
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882